Non Small Cell Lung Cancer

In cancer immunotherapy, one PD-L1 test to rule them all?

Clinical trials have proven the power of immunotherapies targeting PD-L1 or PD-1 in a range of cancers. However, these same trials show that only some patients benefit - tumors must depend on PD-L1 to be affected when medicines ...

Dec 01, 2016
popularity3 comments 0

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Want to give a good gift? Think past the 'big reveal'

Gift givers often make critical errors in gift selection during the holiday season, according to a new research article in Current Directions in Psychological Science, a journal of the Association for Psychological Science.

Autism brain response theory a dead end, study says

A new study out today in the journal Cerebral Cortex challenges the hypothesis that nerve cells in the brains of individuals with Autism Spectrum Disorders do not reliably and consistently respond to external stimuli.